DocWire News Editors

DocwireNews

A study published this summer in Nature Partner Journal Vaccines provides evidence that a tuberculosis vaccine, called Bacillus Calmette-Guerin (BCG), may help lower blood sugar of patients with Type 1 diabetes. Lower blood sugar means less insulin needed for the diabetic, a drug that has become increasingly expensive. 
In their study, researchers injected patients with Type 1 diabetes with two doses of BCG 4 weeks apart, observing 3 of them for 8 years and 9 for 5 years. In the 8-year group, they found that blood sugar levels dropped by 10% in the 3-year time frame after the injections and was sustained at that level for the remainder of the 8 years.Though these results are profound, The American Diabetes Association and a nonprofit group that funds Type 1 diabetes issued a statement claiming that these results are not enough to support altering therapy methods yet. This is in part due to the considerably small cohort size; however, the researchers plan to use a much larger group of patients in the second phase of their clinical trial of BCG testing.Director of the Diabetes Research Institute at the University of Miami, Dr. Camillo Ricordi, is very optimistic about the treatment, but is weary of getting diabetics&rsquo; hopes up too soon. Many other physicians have voiced their support of this method of treatment as well.With insulin costs skyrocketing from $100-200 a month years ago to $400-500 a month now, many diabetics are <a href="https://proddocwire.wpengine.com/docwire-pick/surge-in-prices-causing-diabetics-to-underuse-insulin/">cutting down on insulin use to save money</a>. As a result, they are not managing their condition properly, and may suffer from poor health as a result. If 2 injections of the BCG vaccine can effectively lower blood sugar in patients over several years, at only $157 an injection, then diabetics may be able to significantly reduce their medical expenditure.<blockquote class="twitter-tweet" data-lang="en">
&ldquo;The burden of treatment is why a small study that shows promise for a simpler, cheaper alternative treatment to Type 1 diabetes is being met with hope. But also caution and skepticism.&rdquo; Via <a href="https://twitter.com/cnnhealth?ref_src=twsrc%5Etfw">@cnnhealth</a> <a href="https://t.co/XISi98EdtD">https://t.co/XISi98EdtD</a>
&mdash; MMCAP (@MMCAP_Online) <a href="https://twitter.com/MMCAP_Online/status/1017427329717620738?ref_src=twsrc%5Etfw">July 12, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Sources: <a href="https://www.nature.com/articles/s41541-018-0062-8">Nature Partner Journal Vaccines</a>, <a href="https://www.cnn.com/2018/07/12/health/diabetes-vaccine-partner/index.html">CNN</a>, <a href="https://www.diabetesselfmanagement.com/blog/the-cost-of-insulin/">Diabetes Self-Management</a>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Treating Diabetes with a Tuberculosis Vaccine

Diabetes

A study published this summer in Nature Partner Journal Vaccines provides evidence that a tuberculosis vaccine, called Bacillus Calmette-Guerin (BCG), may help lower blood ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe